-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Neutral on Beta Bionics, Lowers Price Target to $11

Benzinga·05/18/2026 17:32:19
Listen to the news
B of A Securities analyst Travis Steed maintains Beta Bionics (NASDAQ:BBNX) with a Neutral and lowers the price target from $23 to $11.